Abstract:Background: The evaluation and interpretation of the results from blood tests measuring specific immunoglobulin E (IgE) antibody concentration is currently made using the dichotomized result from the test despite a quantitative result is obtained. It has been shown that different levels of IgE antibodies, assessed by blood test and skin prick test, may have a relation to presence of symptoms, implying that there is more information in a quantitative result than in the dichotomous--positive or negative. Objective: To investigate the clinical utility of quantification of IgE antibodies in the diagnosis of allergic patients and whether such procedure has any advantage to the presently dichotomously used sensitivity and specificity at a fixed cut-off. Methods: Data from a previously published study (R. Paganelli, I.J. Ansoteugi, J. Sastre, C.-E. Lange, M.H.W.M. Roovers, H. de Groot, N.B. Lindholm, P.W. Ewan, Allergy, 1998; 53) analysing diagnosis of allergic patients in four different clinics were re-evaluated. In the original study consecutive patients with suspected IgE-mediated allergy had been examined and evaluated according to the clinical routine at each clinic, using case history, physical examination, skin tests and laboratory tests, except the test to be evaluated, and given a "doctors' allergen-specific diagnosis" as positive or negative. In the present study the relation between "doctors' allergen-specific diagnosis", expressed as pos/neg, and the quantitative levels of specific IgE antibody concentration was analysed using a logistic regression model. This presentation of results was also compared with the more common characteristics of sensitivity and specificity, and also with Receiver-operator characteristics (ROC) curves. Results: The used logistic model described the relationship between allergen-specific diagnosis in each study and the levels of IgE antibodies. The shape of the curve illustrated the physicians' disposition for a positive diagnose in the study, in relation to the specific IgE antibody level. Differences in the shape of the curve was found both between allergens within clinics and between clinics for the same allergen. No association could be demonstrated between prevalence and shape of the curve. Conclusions: Conventional sensitivity/specificity figures or ROC concepts only use the qualitative statement of whether IgE is present or not. A risk assessment using the quantitative level of IgE antibody to an allergen increases the utility of the information in clinical context compared with a qualitative statement of whether IgE is present or not. The quantification demonstrated the link between specific IgE antibodies and allergic reactions. The use of objective, well performing quantitative tests should help improve diagnostic accuracy and might provide a way for the patient to understand and manage his or her daily situation and risk for reactions.

Serologic Measurements for Peanut Allergy: Predicting Clinical Severity is Complex

Food allergy severity predictions based on cellular in vitro tests

Diagnosing peanut allergy with skin prick and specific IgE testing

Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy?

Peanut allergy diagnosis in the context of grass pollen sensitization for 125 patients: roles of peanut and cross-reactive carbohydrate determinants specific IgE

A diagnostic approach to IgE-mediated food allergy: A practical algorithm

Combinatorial advantage of Ses i 1-specific IgE and basophil activation for diagnosis of sesame food allergy

Predicting reactivity threshold in children with anaphylaxis to peanut

Variable IgE cross‐reactivity between peanut 2S‐albumins: The case for measuring IgE to both Ara h 2 and Ara h 6

The Natural History of IgE-Mediated Food Allergy: Can Skin Prick Tests and Serum-Specific IgE Predict the Resolution of Food Allergy?

Identifying Region-specific Allergy Sensitization Clusters to Optimize Diagnosis and Reduce Costs

Is Component-Specific Antibody Testing Sufficient to Replace the Oral Food Challenge in the Diagnostics of Peanut-Sensitized Children? A Proof-of-Concept Study

Peanut-specific IgG subclasses as biomarkers of peanut allergy in LEAP study participants

Clinical utility analysis of the Hoxb8 mast cell activation test for the diagnosis of peanut allergy

Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children

Optimizing tools for evaluating challenge outcomes in children with cashew nut allergy

Peanut allergen characterization and allergenicity throughout development

A further evaluation of the clinical use of specific IgE antibody testing in allergic diseases

Diagnosis and management of food allergies: new and emerging options: a systematic review

Can we predict severe reactions during peanut challenges in children?

Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens